Treatment, outcomes, and prognostic factors of ear cancer

Chun Kai Chao, Tzung Shiahn Sheen, Wen Yi Shau, Lai Lei Ting, Mow Ming Hsu

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Cancer of the ear is rare and a consensus has not been reached as to the most appropriate treatment. In this retrospective study, we examined the treatment modalities, prognostic factors, and outcomes of patients treated for ear cancer at the National Taiwan University Hospital during a 15-year period. The disease-free survival rates of patients with three different disease grades were compared using the log-rank test. The effects of prognostic factors on survival were examined with Cox's proportional hazard model. Of the 61 ear cancer patients treated from January 1982 through October 1996, 47 (36 men, 11 women; mean age, 54.6 yr) had complete records and were included in this study. The tumor originated from the middle ear in 29 (62%) patients and from the external ear canal in 18 (38%). A total of 37 patients underwent radical mastoidectomy to remove the gross tumor, while six underwent wide excision of the tumor. Concomitant parotidectomy or neck dissection was performed in seven patients. Thirty-eight patients received postoperative radiation therapy and five patients received chemotherapy for palliative treatment of recurrent or inoperable tumors. All but four (9%) of 43 patients developed facial nerve palsy postoperatively. There were no deaths directly related to surgery or other major complications, including cerebrospinal fluid leakage, meningitis, or hemiparesis. The 5-year disease- free survival rate was 53% overall (n=47), but differed significantly among patients with different grades of disease (p = 0.038): 66% for grade I (n = 27), 44% for grade II (n = 17), and 0% for grade III (n = 3). Multivariate analysis revealed that cervical lymph node metastasis was a poor prognostic factor (relative hazard, 16.4; p < 0.001). These results suggest that mastoidectomy with postoperative radiation therapy can yield satisfactory outcomes, even in some cases of advanced (grade II) disease.

Original languageEnglish
Pages (from-to)314-318
Number of pages5
JournalJournal of the Formosan Medical Association
Volume98
Issue number5
Publication statusPublished - May 1 1999
Externally publishedYes

Fingerprint

Ear Neoplasms
Disease-Free Survival
Neoplasms
Radiotherapy
Survival Rate
Ear Canal
Neck Dissection
Facial Paralysis
Facial Nerve
Paresis
Middle Ear
Taiwan
Palliative Care
Meningitis
Proportional Hazards Models

Keywords

  • Ear cancer
  • Mastoidectomy
  • Radiation therapy
  • Temporal bone

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chao, C. K., Sheen, T. S., Shau, W. Y., Ting, L. L., & Hsu, M. M. (1999). Treatment, outcomes, and prognostic factors of ear cancer. Journal of the Formosan Medical Association, 98(5), 314-318.

Treatment, outcomes, and prognostic factors of ear cancer. / Chao, Chun Kai; Sheen, Tzung Shiahn; Shau, Wen Yi; Ting, Lai Lei; Hsu, Mow Ming.

In: Journal of the Formosan Medical Association, Vol. 98, No. 5, 01.05.1999, p. 314-318.

Research output: Contribution to journalArticle

Chao, CK, Sheen, TS, Shau, WY, Ting, LL & Hsu, MM 1999, 'Treatment, outcomes, and prognostic factors of ear cancer', Journal of the Formosan Medical Association, vol. 98, no. 5, pp. 314-318.
Chao, Chun Kai ; Sheen, Tzung Shiahn ; Shau, Wen Yi ; Ting, Lai Lei ; Hsu, Mow Ming. / Treatment, outcomes, and prognostic factors of ear cancer. In: Journal of the Formosan Medical Association. 1999 ; Vol. 98, No. 5. pp. 314-318.
@article{243efcb97bcb4430b35a4777d677a2b0,
title = "Treatment, outcomes, and prognostic factors of ear cancer",
abstract = "Cancer of the ear is rare and a consensus has not been reached as to the most appropriate treatment. In this retrospective study, we examined the treatment modalities, prognostic factors, and outcomes of patients treated for ear cancer at the National Taiwan University Hospital during a 15-year period. The disease-free survival rates of patients with three different disease grades were compared using the log-rank test. The effects of prognostic factors on survival were examined with Cox's proportional hazard model. Of the 61 ear cancer patients treated from January 1982 through October 1996, 47 (36 men, 11 women; mean age, 54.6 yr) had complete records and were included in this study. The tumor originated from the middle ear in 29 (62{\%}) patients and from the external ear canal in 18 (38{\%}). A total of 37 patients underwent radical mastoidectomy to remove the gross tumor, while six underwent wide excision of the tumor. Concomitant parotidectomy or neck dissection was performed in seven patients. Thirty-eight patients received postoperative radiation therapy and five patients received chemotherapy for palliative treatment of recurrent or inoperable tumors. All but four (9{\%}) of 43 patients developed facial nerve palsy postoperatively. There were no deaths directly related to surgery or other major complications, including cerebrospinal fluid leakage, meningitis, or hemiparesis. The 5-year disease- free survival rate was 53{\%} overall (n=47), but differed significantly among patients with different grades of disease (p = 0.038): 66{\%} for grade I (n = 27), 44{\%} for grade II (n = 17), and 0{\%} for grade III (n = 3). Multivariate analysis revealed that cervical lymph node metastasis was a poor prognostic factor (relative hazard, 16.4; p < 0.001). These results suggest that mastoidectomy with postoperative radiation therapy can yield satisfactory outcomes, even in some cases of advanced (grade II) disease.",
keywords = "Ear cancer, Mastoidectomy, Radiation therapy, Temporal bone",
author = "Chao, {Chun Kai} and Sheen, {Tzung Shiahn} and Shau, {Wen Yi} and Ting, {Lai Lei} and Hsu, {Mow Ming}",
year = "1999",
month = "5",
day = "1",
language = "English",
volume = "98",
pages = "314--318",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Treatment, outcomes, and prognostic factors of ear cancer

AU - Chao, Chun Kai

AU - Sheen, Tzung Shiahn

AU - Shau, Wen Yi

AU - Ting, Lai Lei

AU - Hsu, Mow Ming

PY - 1999/5/1

Y1 - 1999/5/1

N2 - Cancer of the ear is rare and a consensus has not been reached as to the most appropriate treatment. In this retrospective study, we examined the treatment modalities, prognostic factors, and outcomes of patients treated for ear cancer at the National Taiwan University Hospital during a 15-year period. The disease-free survival rates of patients with three different disease grades were compared using the log-rank test. The effects of prognostic factors on survival were examined with Cox's proportional hazard model. Of the 61 ear cancer patients treated from January 1982 through October 1996, 47 (36 men, 11 women; mean age, 54.6 yr) had complete records and were included in this study. The tumor originated from the middle ear in 29 (62%) patients and from the external ear canal in 18 (38%). A total of 37 patients underwent radical mastoidectomy to remove the gross tumor, while six underwent wide excision of the tumor. Concomitant parotidectomy or neck dissection was performed in seven patients. Thirty-eight patients received postoperative radiation therapy and five patients received chemotherapy for palliative treatment of recurrent or inoperable tumors. All but four (9%) of 43 patients developed facial nerve palsy postoperatively. There were no deaths directly related to surgery or other major complications, including cerebrospinal fluid leakage, meningitis, or hemiparesis. The 5-year disease- free survival rate was 53% overall (n=47), but differed significantly among patients with different grades of disease (p = 0.038): 66% for grade I (n = 27), 44% for grade II (n = 17), and 0% for grade III (n = 3). Multivariate analysis revealed that cervical lymph node metastasis was a poor prognostic factor (relative hazard, 16.4; p < 0.001). These results suggest that mastoidectomy with postoperative radiation therapy can yield satisfactory outcomes, even in some cases of advanced (grade II) disease.

AB - Cancer of the ear is rare and a consensus has not been reached as to the most appropriate treatment. In this retrospective study, we examined the treatment modalities, prognostic factors, and outcomes of patients treated for ear cancer at the National Taiwan University Hospital during a 15-year period. The disease-free survival rates of patients with three different disease grades were compared using the log-rank test. The effects of prognostic factors on survival were examined with Cox's proportional hazard model. Of the 61 ear cancer patients treated from January 1982 through October 1996, 47 (36 men, 11 women; mean age, 54.6 yr) had complete records and were included in this study. The tumor originated from the middle ear in 29 (62%) patients and from the external ear canal in 18 (38%). A total of 37 patients underwent radical mastoidectomy to remove the gross tumor, while six underwent wide excision of the tumor. Concomitant parotidectomy or neck dissection was performed in seven patients. Thirty-eight patients received postoperative radiation therapy and five patients received chemotherapy for palliative treatment of recurrent or inoperable tumors. All but four (9%) of 43 patients developed facial nerve palsy postoperatively. There were no deaths directly related to surgery or other major complications, including cerebrospinal fluid leakage, meningitis, or hemiparesis. The 5-year disease- free survival rate was 53% overall (n=47), but differed significantly among patients with different grades of disease (p = 0.038): 66% for grade I (n = 27), 44% for grade II (n = 17), and 0% for grade III (n = 3). Multivariate analysis revealed that cervical lymph node metastasis was a poor prognostic factor (relative hazard, 16.4; p < 0.001). These results suggest that mastoidectomy with postoperative radiation therapy can yield satisfactory outcomes, even in some cases of advanced (grade II) disease.

KW - Ear cancer

KW - Mastoidectomy

KW - Radiation therapy

KW - Temporal bone

UR - http://www.scopus.com/inward/record.url?scp=0032815005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032815005&partnerID=8YFLogxK

M3 - Article

VL - 98

SP - 314

EP - 318

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 5

ER -